ATP2B4
Plasma membrane calcium-transporting ATPase 4
Also known as: AT2B4_HUMAN, ATP2B2, MXRA1, PMCA4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P23634
- Gene
- ATP2B4
- Ensembl
- ENSG00000058668
- Chromosome
- 1
- Canonical length
- 1241 aa
- Protein class
- Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Plasma membrane,Primary cilium,Mitochondria,Basal body
OverviewNCBI Gene
The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1241 residues, UniProt reviewed canonical sequence.
>P23634|ATP2B4
1 MTNPSDRVLP ANSMAESREG DFGCTVMELR KLMELRSRDA LTQINVHYGG VQNLCSRLKT
61 SPVEGLSGNP ADLEKRRQVF GHNVIPPKKP KTFLELVWEA LQDVTLIILE IAAIISLVLS
121 FYRPAGEENE LCGQVATTPE DENEAQAGWI EGAAILFSVI IVVLVTAFND WSKEKQFRGL
181 QCRIEQEQKF SIIRNGQLIQ LPVAEIVVGD IAQVKYGDLL PADGILIQGN DLKIDESSLT
241 GESDHVKKSL DKDPMLLSGT HVMEGSGRMV VTAVGVNSQT GIILTLLGVN EDDEGEKKKK
301 GKKQGVPENR NKAKTQDGVA LEIQPLNSQE GIDNEEKDKK AVKVPKKEKS VLQGKLTRLA
361 VQIGKAGLLM SALTVFILIL YFVIDNFVIN RRPWLPECTP IYIQYFVKFF IIGITVLVVA
421 VPEGLPLAVT ISLAYSVKKM MKDNNLVRHL DACETMGNAT AICSDKTGTL TMNRMTVVQA
481 YIGGIHYRQI PSPDVFLPKV LDLIVNGISI NSAYTSKILP PEKEGGLPRQ VGNKTECALL
541 GFVTDLKQDY QAVRNEVPEE KLYKVYTFNS VRKSMSTVIR NPNGGFRMYS KGASEIILRK
601 CNRILDRKGE AVPFKNKDRD DMVRTVIEPM ACDGLRTICI AYRDFDDTEP SWDNENEILT
661 ELTCIAVVGI EDPVRPEVPD AIAKCKQAGI TVRMVTGDNI NTARAIATKC GILTPGDDFL
721 CLEGKEFNRL IRNEKGEVEQ EKLDKIWPKL RVLARSSPTD KHTLVKGIID STVGEHRQVV
781 AVTGDGTNDG PALKKADVGF AMGIAGTDVA KEASDIILTD DNFTSIVKAV MWGRNVYDSI
841 SKFLQFQLTV NVVAVIVAFT GACITQDSPL KAVQMLWVNL IMDTFASLAL ATEPPTESLL
901 KRRPYGRNKP LISRTMMKNI LGHAFYQLIV IFILVFAGEK FFDIDSGRKA PLHSPPSQHY
961 TIVFNTFVLM QLFNEINSRK IHGEKNVFSG IYRNIIFCSV VLGTFICQIF IVEFGGKPFS
1021 CTSLSLSQWL WCLFIGIGEL LWGQFISAIP TRSLKFLKEA GHGTTKEEIT KDAEGLDEID
1081 HAEMELRRGQ ILWFRGLNRI QTQIDVINTF QTGASFKGVL RRQNMGQHLD VKLVPSSSYI
1141 KVVKAFHSSL HESIQKPYNQ KSIHSFMTHP EFAIEEELPR TPLLDEEEEE NPDKASKFGT
1201 RVLLLDGEVT PYANTNNNAV DCNQVQLPQS DSSLQSLETS VLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP2B4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 165 nTPM
Expression across tissuesHPA
Tissue
- smooth muscle: 165 nTPM
- endometrium: 98 nTPM
- seminal vesicle: 66 nTPM
- heart muscle: 56 nTPM
- adipose tissue: 55 nTPM
- skin: 52 nTPM
Single-cell type
- suprabasal keratinocytes: 691 nCPM
- basal keratinocytes: 497 nCPM
- alveolar cells type 1: 486 nCPM
- smooth muscle cells: 476 nCPM
- ocular epithelial cells: 453 nCPM
- müller glia: 373 nCPM
Immune cell
- gdT-cell: 8.7 nTPM
- memory CD8 T-cell: 7.2 nTPM
- MAIT T-cell: 6.5 nTPM
- T-reg: 5.8 nTPM
- memory CD4 T-cell: 5.5 nTPM
- neutrophil: 4.1 nTPM
Brain region
- hypothalamus: 175 nTPM
- amygdala: 166 nTPM
- cerebral cortex: 164 nTPM
- basal ganglia: 156 nTPM
- hippocampal formation: 120 nTPM
- pons: 110 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.44
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.25
- DepMap mean gene effect
- -0.19
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium ion export
- calcium ion import across plasma membrane
- calcium ion transmembrane import into cytosol
- calcium ion transmembrane transport
- cellular response to acetylcholine
- cellular response to epinephrine stimulus
- flagellated sperm motility
- hippocampus development
- intracellular calcium ion homeostasis
- monoatomic ion transmembrane transport
- negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway
- negative regulation of angiogenesis
- negative regulation of blood vessel endothelial cell migration
- negative regulation of calcineurin-NFAT signaling cascade
- negative regulation of cardiac muscle hypertrophy in response to stress
- negative regulation of cellular response to vascular endothelial growth factor stimulus
- negative regulation of gene expression
- negative regulation of nitric oxide biosynthetic process
- neural retina development
- nitric oxide-cGMP-mediated signaling
- positive regulation of protein localization to plasma membrane
- regulation of cardiac conduction
- regulation of cell cycle G1/S phase transition
- regulation of cytosolic calcium ion concentration
- regulation of sodium ion transmembrane transport
- regulation of transcription by RNA polymerase II
- response to hydrostatic pressure
- spermatogenesis
- transport across blood-brain barrier
- urinary bladder smooth muscle contraction
- negative regulation of arginine catabolic process
- negative regulation of citrulline biosynthetic process
- negative regulation of the force of heart contraction
Molecular functions
- ATP binding
- ATP hydrolysis activity
- calcium ion transmembrane transporter activity
- calmodulin binding
- metal ion binding
- nitric-oxide synthase binding
- nitric-oxide synthase inhibitor activity
- P-type calcium transporter activity
- PDZ domain binding
- protein kinase binding
- protein phosphatase 2B binding
- scaffold protein binding
- sodium channel regulator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- P-type ATPase
- Cation-transporting P-type ATPase, N-terminal
- Cation-transporting P-type ATPase, C-terminal
- P-type ATPase, subfamily IIB
- P-type ATPase, A domain superfamily
- P-type ATPase, phosphorylation site
- Plasma membrane calcium transporting P-type ATPase, C-terminal
- HAD superfamily
- P-type ATPase, transmembrane domain superfamily
- P-type ATPase, cytoplasmic domain N
- HAD-like superfamily
- P-type ATPase, haloacid dehalogenase domain
- P-type ATPase, A domain
- P-type ATPase actuator domain
- Cation transporting ATPase, C-terminus
- Cation transporter/ATPase, N-terminus
- haloacid dehalogenase-like hydrolase
- Plasma membrane calcium transporter ATPase C terminal
- P-type ATPase, cytoplasmic domain N
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP2B4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP2B4 as an antibody target. Whether an autoantibody or antibody against ATP2B4 could matter depends on whether native ATP2B4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP2B4 is annotated at the cell surface, where native ATP2B4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ATP2B4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...